Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

B2B sales

FDA shares new #socialmedia guidance

Latest recommendations cover Twitter, paid search links and correcting misinformation

Gilead Sciences

Sovaldi stumbles as NICE assesses hep C drug’s price

Gilead must provide much more cost-effectiveness information

- PMLiVE

Merck KGaA drops Ono-partnered multiple sclerosis drug

Decides phase III candidate ceralifimod isn't worth its continued investment

- PMLiVE

UCB taps EU for €75m in R&D funding

Agrees innovative risk-sharing finance deal with European Investment Bank

- PMLiVE

ADA: Merck launches registry for type 2 diabetes

Will collect information from 20,000 patients across four countries

- PMLiVE

ADA: Empagliflozin overcomes FDA concerns

Boehringer and Lilly expect decision on diabetes treatment by end of 2014

- PMLiVE

Counting value under the US Sunshine Act

International in scope, the implication of the transparency legislation are anything but clear

- PMLiVE

Fishawack appoints John Handley as new chairman

He joins to support UK group's acquisition plans

- PMLiVE

Designing unique patient solutions in rare disease

Living with any chronic health condition can be demanding, but rare diseases bring a unique set of challenges for patients.

As Apple’s HealthKit is to iOS so could Google Fit be to Android?

Google said to be readying health data service of its own

- PMLiVE

Michael Le Brocq joins Langland

Takes up role as business unit director

- PMLiVE

Omontys terminal as Takeda switches off support

Japanese company ends anaemia treatment partnership with Affymax

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links